Prognostic value of initial prostate-specific antigen levels after salvage cryoablation for prostate cancer

BJU International

Volumn 106, Issue 7, 2010, Pages 986-990

  Levy, David A ^a   Pisters, Louis L ^b   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

outcomes; prostate cancer; PSA; salvage cryoablation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CANCER THERAPY; CRYOABLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; SALVAGE THERAPY; CRYOSURGERY; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CRYOSURGERY; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 77956622262     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09297.x     Document Type: Article

References (26)

1. Pisters LL, von Eschenbach AC, Scott SM et al. The efficacy and complications of salvage cryotherapy of the prostate. J Urol 1997 157 : 921 925
2. Ghafar MA, Johnson CW, De La Taille A et al. Salvage cryotherapy using an argon based system for locally recurrent prostate cancer after radiation therapy: the Columbia experience. J Urol 2001 166 : 1333 1337
3. Chin JL, Pautler SE, Mouraviev V, Touma N, Moore K, Downey DB. Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 2001 165 : 1937 1941
4. Roach M III., Hanks G, Thames H et al. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 2006 65 : 965 974
5. Cookson MS, Aus G, Burnett AL. Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 2007 177 : 540 545
6. Wiegel T, Lohm G, Hocht S et al. Achieveing an undetectable PSA after radiotherapy for biochemical progression after radical prostatectomy is an independent predictor of biochemical outcome - results of a retrospective study. Int J Radiat Oncol Biol Phys 2009 73 : 1009 1016
7. Pasquier D, Ballereau C. Adjuvant and salvage radiotherapy after prostatectomy for prostate cancer: a literature review. Int J Radiat Oncol Biol Phys 2008 72 : 972 979
8. De Meerleer G, Fonteyne V, Meersschout S et al. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy. Radiother Oncol 2008 89 : 205 213
9. Pisters LL, Leibovici D, Blute M et al. Locally recurrent prostate cancer after initial radiation therapy. A comparison of salvage radical prostatectomy versus cryotherapy. J Urol 2009 182 : 517 525
10. Leibovici D, Spiess PE, Heller L, Rodriguez-Bigas M, Chang G, Pisters LL. Salvage surgery for locally recurrent prostate cancer after radiation therapy: trick of the trade. Urol Oncol 2008 26 : 9 16
11. Sanderson KM, Penson DF, Cai J et al. Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 2006 176 : 2025 2031
12. Izawa JI, Perrotte P, Greene GF et al. Local tumor control with salvage cryotherapy for locally recurrent prostate cancer after external beam radiotherapy. J Urol 2001 165 : 867 870
13. Izawa JI, Madsen LT, Scott SM et al. Slavage cryotherapy for recurrent prostate cancer after radiotherapy: variables affecting patient outcome. J Clin Oncol 2002 20 : 2664 2671
14. Spiess PE, Lee AK, Leibovici D, Wang X, Do KA, Pisters LL. Presalvage prostate-specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy. Cancer 2006 15 : 275 280
15. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus Statement. Guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997 37 : 1035 1041
16. Babaian RJ, Donnelly B, Bahn D et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol 2008 180 : 1993 1904
17. Levy DA, Pisters LL, Jones JS. Primary cryoablation nadir PSA and biochemical failure rates. J Urol 2009 182 : 931 937
18. D'Amico AV, Moul J, Carroll PR, Sun L, Lubeck D, Chen MH. Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate specific antigen era. J Clin Oncol 2003 21 : 2163 2172
19. Levy DA, Li J, Jones JS. Impact of disease burden on cryoablation PSA outcomes. Urology 2010 75 : 478 481
20. Karakiewicz PI, Bhojani N, Capitanio U et al. External validation of the updated Partin tables in a cohort of North American men. J Urol 2008 180 : 898 902
21. Bhojani N, Salomon L, Capitanio U et al. External validation of the updated Partin tables in a cohort of French and Italian men. Int J Radiat Oncol Biol Phys 2009 73 : 347 352
22. Molitierno J, Evans A, Mohler JL, Wallen E, Moore D, Pruthi RS. Characterization of biochemical recurrence after radical prostatectomy. Urol Int 2006 77 : 130 134
23. Sengupta S, Christensen CM, Zinke H et al. Detectable prostate specific antigen 60 and 120 days following radical prostatectomy for prostate cancer. Natural history and prognostic significance. J Urol 2006 176 : 559 63
24. Lin DD, Schultz D, Renshaw AA, Rubin MA, Richie JP, D'Amico AV. Predictors of short postoperative prostate specific antigen doubling time for patients diagnosed during the PSA era. Urology 2005 65 : 528 532
25. Teeter AE, Banez LL, Presti JC et al. What are factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group. J Urol 2008 180 : 1980 1984
26. Naselli A, Introini C, Andreatta R, Spina B, Truini M, Puppo P. Prognostic factors of persistently detectable PSA after radical prostatectomy. Int J Urol 2009 16 : 82 6